Sandoz : Pyzchiva Approved In Europe For Gastroenterology, Dermatology, And Rheumatology Treatments
22/4 07:32
(RTTNews) - Sandoz (SDZNY) said that the European Commission has granted marketing authorization for Pyzchiva (biosimilar ustekinumab), developed and registered by Samsung Bioepis. Pyzchiva is approved as a biologic therapy within gastroenterology, dermatology, and rheumatology....